Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Directionality of noncoding human RNAs: How to avoid artifacts
Sivan Tzadok
, Yarden Caspin
, Yafit Hachmo
,
Dan Canaani
,
Iris Dotan
*
*
Corresponding author for this work
Biochemistry Molecular Biology
Internal Medicine
Tel Aviv University
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Directionality of noncoding human RNAs: How to avoid artifacts'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Non-coding
100%
Long Non-coding RNA (LncRNA)
100%
Metastasis Suppressor
100%
Quantitative PCR
66%
Tumor Suppressor
66%
Tumor Metastasis
66%
Epigenetic Silencing
66%
Breast Cancer Cell Lines
33%
Overexpressing
33%
Human Tumors
33%
Tumor Suppressor Gene
33%
Carcinoma Cell Lines
33%
Human Cancer
33%
Human Epidermal Growth Factor Receptor 2 (HER2)
33%
Elevated Temperature
33%
Antisense
33%
Breast Carcinoma Cells
33%
False Detection
33%
Triple Negative
33%
Chromatin Silencing
33%
Periodate
33%
Bidirectional Transcription
33%
RNA Preparation
33%
CST6
33%
Breast Cancer Metastasis Suppressor 1 (BRMS1)
33%
Long Noncoding
33%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
RNA
100%
Suppressor Gene
75%
Metastasis Suppressor
75%
Tumor Suppressor Protein
50%
Epigenetics
50%
Reverse Transcription Polymerase Chain Reaction
50%
Cancer Cell
25%
Transcription
25%
Antisense
25%
Tumor Suppressor Gene
25%
Long Noncoding RNA
25%
Periodate
25%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Suppressor Protein
100%
Breast Cancer
33%
Breast Carcinoma
33%
Periodate
33%
Long Untranslated RNA
33%